<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T08:38:40Z</responseDate>
  <request identifier="oai:figshare.com:article/33990793" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33990793</identifier>
        <datestamp>2026-09-24T20:08:26Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Untargeted
Metabolomics for PM&lt;sub&gt;2.5&lt;/sub&gt; Toxicity
in Rodent Models: A Systematic Review</dc:title>
          <dc:creator>Mengyao Wang (829984)</dc:creator>
          <dc:creator>Xiaona Wang (662335)</dc:creator>
          <dc:creator>Chenglei Qi (23066922)</dc:creator>
          <dc:creator>Keke Long (22275280)</dc:creator>
          <dc:creator>Shuling Duan (23634333)</dc:creator>
          <dc:creator>Yingyang He (23688713)</dc:creator>
          <dc:creator>Jiajun Xiao (22307069)</dc:creator>
          <dc:creator>Shuyi Zhang (34553)</dc:creator>
          <dc:creator>Yu Wang (12152)</dc:creator>
          <dc:creator>Mu Zhu (62830)</dc:creator>
          <dc:creator>Xiaoyan Yang (259084)</dc:creator>
          <dc:creator>Qiong Wang (117288)</dc:creator>
          <dc:creator>Yuanyuan Chen (165812)</dc:creator>
          <dc:creator>Chao Wang (146527)</dc:creator>
          <dc:creator>Wen Gu (129075)</dc:creator>
          <dc:creator>Song Tang (586283)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>standardized analytical workflows</dc:subject>
          <dc:subject>specific metabolic alterations</dc:subject>
          <dc:subject>relatively unbiased profiling</dc:subject>
          <dc:subject>offers unique opportunities</dc:subject>
          <dc:subject>mediated epigenetic dysregulation</dc:subject>
          <dc:subject>g ., taurine</dc:subject>
          <dc:subject>fine particulate matter</dc:subject>
          <dc:subject>driven redox imbalance</dc:subject>
          <dc:subject>complementary platform integration</dc:subject>
          <dc:subject>276 unique exposure</dc:subject>
          <dc:subject>linoleic acid metabolism</dc:subject>
          <dc:subject>adverse health effects</dc:subject>
          <dc:subject>5 &lt;/ sub</dc:subject>
          <dc:subject>health concern</dc:subject>
          <dc:subject>citric acid</dc:subject>
          <dc:subject>untargeted metabolomics</dc:subject>
          <dc:subject>throughput approach</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>study comparisons</dc:subject>
          <dc:subject>species validation</dc:subject>
          <dc:subject>rodent models</dc:subject>
          <dc:subject>provides global</dc:subject>
          <dc:subject>pressing public</dc:subject>
          <dc:subject>molecule metabolites</dc:subject>
          <dc:subject>frequency metabolites</dc:subject>
          <dc:subject>emerging contaminants</dc:subject>
          <dc:subject>conventional approaches</dc:subject>
          <dc:subject>associated metabolites</dc:subject>
          <dc:subject>applicable framework</dc:subject>
          <dc:subject>animal models</dc:subject>
          <dc:description>The adverse health effects of fine particulate matter
(PM&lt;sub&gt;2.5&lt;/sub&gt;) remain a pressing public-health concern. Untargeted
metabolomics,
which provides global and relatively unbiased profiling of small-molecule
metabolites, offers unique opportunities to discover new exposure
biomarkers and clarify toxicity mechanisms beyond those of conventional
approaches. This systematic review synthesizes 42 untargeted metabolomics
studies in PM&lt;sub&gt;2.5&lt;/sub&gt;-exposed rodent models. Integrative analysis
identifies 1,276 unique exposure-associated metabolites under the
predefined lenient screening criteria, with 24 high-frequency metabolites
(e.g., taurine, citric acid, alanine) and 31 recurrently perturbed
pathways (e.g., purine metabolism, linoleic acid metabolism, and tricarboxylic
acid cycle). These convergent alterations suggest three recurring
mechanistic themes: an energy-crisis-driven redox imbalance, oxidative-stress-mediated
epigenetic dysregulation, and inflammatory signaling via polyunsaturated
fatty acids. Tissue-specific metabolic alterations were prominent
in lungs (e.g., altered arachidonic acid), liver (e.g., purine catabolism),
and brain (e.g., lipid homeostasis disruption), demonstrating multiorgan
pathophysiological responses. Nevertheless, substantial methodological
heterogeneity across exposure protocols, animal models, and analytical
platforms complicates cross-study comparisons. These findings support
untargeted metabolomics as a high-throughput approach for characterizing
PM&lt;sub&gt;2.5&lt;/sub&gt;-induced metabolic toxicity and offer an applicable
framework that may also inform studies of other emerging contaminants
and mixtures. Further progress will require more standardized analytical
workflows, complementary platform integration, and cross-species validation.</dc:description>
          <dc:date>2026-09-24T00:00:00Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1021/acs.chemrestox.6c00257.s003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Untargeted_Metabolomics_for_PM_sub_2_5_sub_Toxicity_in_Rodent_Models_A_Systematic_Review/33990793</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
